Jubilant Life Sciences, formerly known as Jubilant Organosys, has recorded a 42% growth in its consolidated net profit in the second quarter ending September 30, 2010.
The company’s net profit was R82 crore for the quarter, against R58 crore in July-September a year ago.
“The strong growth has been driven by robust sales in agri products which are expected to continue,” said Shyam S Bhartia, chairman and managing director, Jubilant Life Sciences.
Agri and Performance Polymers (APP) segment contributed 14% towards company’s consolidated revenue. Jubilant is de-merging its APP business into an independent entity, which will function as Jubilant Industries and will be listed by next year, according to R Sankaraiah, executive director, Jubilant Life Sciences.